Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and hepatitis C.

Christian P Strassburg1, Arndt Vogel, Michael P Manns

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. strassburg.christian@mh-hannover.de

Autoimmunity Reviews
|October 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial.

JAMA oncology·2026
Same author

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same author

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

International journal of cancer·2026
Same author

Trends in the incidence and surgical treatment of hepatocellular carcinoma in Ontario.

Canadian journal of surgery. Journal canadien de chirurgie·2026
Same author

Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

Nature reviews. Clinical oncology·2026

Hepatitis C shares similarities with autoimmune hepatitis, often presenting overlapping symptoms and autoantibodies. Research explores the immunological links between viral infections like Hepatitis C and the development of autoimmunity.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Hepatitis C (HCV) is a chronic liver disease causing cirrhosis and portal hypertension.
  • HCV shares clinical and biochemical features with autoimmune hepatitis (AIH), a liver disease caused by loss of self-tolerance.
  • Distinguishing HCV from AIH is possible via viral markers, yet overlapping immune phenomena exist.

Purpose of the Study:

  • To review general immunological mechanisms linking viral infections with autoimmunity.
  • To examine specific features of Hepatitis C- and D-associated autoimmunity.
  • To investigate the role of viral infections in driving autoimmune diseases.

Main Methods:

  • Literature review focusing on immunological mechanisms.
  • Analysis of studies investigating autoimmunity in Hepatitis C and D patients.

Related Experiment Videos

  • Examination of molecular and cellular research on viral infections and autoimmunity.

    • Main Results:

    • Autoantibodies common in AIH are frequently found in HCV patients.
    • HCV patients exhibit a range of immune-mediated symptoms and diseases.
    • Viral infections are central to understanding the forces driving human autoimmunity.

    Conclusions:

    • Hepatitis C and autoimmune hepatitis present overlapping immunological features.
    • Viral infections, particularly HCV, are implicated in the development of autoimmunity.
    • Further research into viral-driven autoimmunity is crucial for understanding and treating autoimmune diseases.